SEC Form 4 · accession 0000850261-18-000021
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ji
Officer — See Remarks · Director
Period of report
May 17, 2018
Accepted (ET)
May 17, 2018 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $7.20 | May 17, 2018 | A | 750,000 | A | — | May 17, 2028 | Common Stock | 750,000 | 750,000 | D |
Explanation of responses
- F11/4th of the original number of shares subject to the option shall vest on May 17, 2019 and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after May 17, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Remarks
President, CEO and Chairman of the Board of Directors